Early access treatment is an override mechanism that allows patients to access new treatments that are not yet approved (pre-MAM early access) or not yet reimbursed (post-MAM early access). These treatments may be an additional treatment option for cancer patients.
In case of eligibility, i.e. if you meet the criteria for the indication of the treatment available at early access, your oncologist can make a request directly to the manufacturer's laboratory so that you can benefit from it.
Neo-adjuvant therapy : Neoadjuvant therapy is a type of treatment used to treat cancer before surgery. Most often, the aim of neoadjuvant therapy is to reduce the size of the tumor before surgery.
Adjuvant therapy : Adjuvant therapy is a type of treatment that is used after surgery to treat cancer.
Neoadjuvant and adjuvant therapy may include:
There are other treatments available through clinical trials
With Klineo, you can find the clinical trials that are right for you. To do this, it is important to enter the treatments received in order to find relevant clinical trials. This information can be found in the recent consultation report.
Treatments used to treat metastatic cancer are called “processing lines”. A treatment line may include:
Example:
There are other treatments available through clinical trials.
With Klineo, you can find the clinical trials that are right for you. To do this, it is important to enter the treatments received in order to find relevant clinical trials. This information can be found in the recent consultation report.
How to find early access to the platform?
During a search, if your criteria match the treatment (s) currently available for early access, you will find the list of these treatments in the “Early Access” tab.